SCHEMBL5936244

SCHEMBL5936244

CCC1(CC)CCSC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6124703 0.85
SCHEMBL10226988 0.84
SCHEMBL14754642 0.82
SCHEMBL23606048 0.82
SCHEMBL14755772 0.74
SCHEMBL25814133 0.74
SCHEMBL18708672 0.72
SCHEMBL23490770 0.71
SCHEMBL15894644 0.69
SCHEMBL14467768 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111240118-B Electrochromic device with three-electrode structure and preparation method thereof 浙江工业大学 2023-07-14 CN claimed
CN-111240118-A Novel electrochromic device with three-electrode structure and preparation method thereof 浙江工业大学 2020-06-05 CN claimed
CN-111240118-B Electrochromic device with three-electrode structure and preparation method thereof 浙江工业大学 2023-07-14 CN disclosed
CN-111240118-A Novel electrochromic device with three-electrode structure and preparation method thereof 浙江工业大学 2020-06-05 CN disclosed
US-20170066763-A1 TYK2 INHIBITORS AND USES THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-03-09 US disclosed
CN-101960374-B Electrochromic device 3M INNOVATIVE PROPERTIES CO 2013-09-11 CN disclosed
US-20130060023-A1 Compounds useful for treating neurodegenerative disorders SATORI PHARMACEUTICALS, INC. (US) 2013-03-07 US disclosed
US-20130060024-A1 Compounds useful for treating neurodegenerative disorders SATORI PHARMACEUTICALS, INC. (US) 2013-03-07 US disclosed
US-8173700-B2 Salts of substituted allophanates and their use in drugs GRUENENTHAL GMBH (DE) 2012-05-08 US disclosed
US-8101603-B2 Tyrosine kinase inhibitors MERCK SHARP & DOHME CORP. (US) 2012-01-24 US disclosed
CN-101960374-A Electrochromic device 3M INNOVATIVE PROPERTIES CO 2011-01-26 CN disclosed
US-7427637-B2 Mitotic kinesin inhibitors MERCK & CO. INC. (US) 2008-09-23 US disclosed
US-20080194582-A1 3,5-Diphenyl-4,5-dihydro-1H-dipyrazole derivatives such as {2-[1-acetyl-3-(2,5-difluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-5-yl]ethyl}(dimethyl)silanol that are useful for treating cancer MERCK SHARP & DOHME CORP. 2008-08-14 US disclosed
US-7396832-B2 Inhibitors of Akt activity MERCK & CO., INC. (US) 2008-07-08 US disclosed
US-7378411-B2 Substituted thienopyrimidinones as a mitotic kinesin inhibitor MERCK & CO., INC. (US) 2008-05-27 US disclosed
US-7348440-B2 Kinesin spindle protein (KSP) inhibitors, e.g., 4-(2,5-Difluorophenyl)-N-[(3S,4S)-3-fluoropiperidin-4-yl]-2-hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1N-pyrrole-1-carboxamide, and a carrier; antiproliferative and -carcinogenic agents; side effects reduction; used with an estrogen receptor modulator MERCK & CO., INC. (US) 2008-03-25 US disclosed
US-7273869-B2 Inhibitors of Akt activity MERCK & CO., INC. (US) 2007-09-25 US disclosed
US-7262186-B2 Substituted pyrazolo[3,4-d] pyrimidinones as a mitotic kinesin inhibitor MERCK & CO., INC. (US) 2007-08-28 US disclosed
US-20070149536-A1 Inhibitors of Akt activity MERCK SHARP & DOHME CORP. 2007-06-28 US disclosed
US-7223738-B2 Inhibitors of Akt activity MERCK & CO., INC. (US) 2007-05-29 US disclosed